Skip to content

Long-term curative effect evaluation and cost-effectiveness analysis of "Tiaoshen acupuncture" in the treatment of moderate to severe persistent allergic rhinitis

Long-term curative effect evaluation and cost-effectiveness analysis of "Tiaoshen acupuncture" in the treatment of moderate to severe persistent allergic rhinitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000318
Enrollment
Unknown
Registered
2025-02-18
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Treatment group:Acupuncture therapy

Sponsors

Tsinghua University Yuquan Hospital (Tsinghua University Hospital of Integrated Chinese and Western Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of moderate to severe persistent AR and are in the stage of symptom attack at the time of visit. (2) The severity of the disease was moderate to severe and the course of the disease was =1 year. (3) The presence of specific allergens or sensitive inhalants and a clear personal history of past illness. (4) Age 18-70 years old. (5) The patient has clear consciousness and clear speech and can cooperate with acupuncture treatment. (6) Stop taking AR related drugs 1 week before participating in the trial. (7) Voluntary subjects signed informed consent good compliance can cooperate with follow-up.

Exclusion criteria

Exclusion criteria: (1) Had respiratory infection within 2 weeks. (2) Patients with acute sinusitis or active asthma. (3) Abnormal nasal structure or accompanied by nasal polyps. (4) Have taken antihistamines glucocorticoids or antibiotics in the past 1 week. (5) Received systemic hormone therapy within 6 months or specific immunotherapy within 1 year. (6) Received acupuncture or Chinese medicine treatment for allergic rhinitis within 2 weeks. (7) Patients with severe cardiovascular and cerebrovascular liver kidney and hematopoietic system and other primary diseases mental patients. (8) Pregnant or lactating women.

Design outcomes

Secondary

MeasureTime frame
AR drug use scores during treatment and within 1 year after treatment;AR drug use score within 1 year post-treatment;Total Non Nasal Symptom Score;Rhinoconjunctivitis Quality of Life Questionnaire;Cost-effectiveness analysis;

Primary

MeasureTime frame
Total Nasal Symptom Score;

Countries

CHINA

Contacts

Public ContactJIE JI

Tsinghua University Yuquan Hospital (Tsinghua University Hospital of Integrated Chinese and Western Medicine)

jjwyw2002@163.com13810438662

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026